NEUP
Neuphoria Therapeutics Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$3.70
−0.40%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-15.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jan 21, 2026 | Wilson David Ian · director | A-Award | 8,537 | $0.00 |
| Jan 21, 2026 | Davies Peter Miles Winston · director | A-Award | 8,537 | $0.00 |
| Jan 21, 2026 | Fisher Alan · director | A-Award | 17,073 | $0.00 |
| Jan 21, 2026 | Ryan Jane · director | A-Award | 8,537 | $0.00 |
| Oct 23, 2025 | Lynx1 Capital Management LP · 10 percent owner | Purchase | 639,110 | $5.14 |
| Sep 2, 2025 | Papapetropoulos Spyros · director, officer: President and CEO | A-Award | 34,559 | $8.27 |
| May 19, 2025 | Papapetropoulos Spyros · director, officer: President and CEO | A-Award | 27,000 | $5.16 |
| Apr 18, 2025 | Papapetropoulos Spyros · director, officer: President and CEO | A-Award | 270,000 | $5.16 |
| Apr 18, 2025 | Davies Peter Miles Winston · director | A-Award | 6,783 | $0.00 |
| Apr 18, 2025 | Ryan Jane · director | A-Award | 6,783 | $0.00 |
| Apr 18, 2025 | Wilson David Ian · director | A-Award | 6,783 | $0.00 |
| Apr 18, 2025 | Fisher Alan · director | A-Award | 13,566 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 12Increased 11Reduced 5Sold out 3
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Lynx1 Capital Management LP | Unchanged | 875,328 | Aug 13, 2026 |
| LYNX1 CAPITAL MANAGEMENT LP | Increased | 875,328 | May 4, 2026 |
| AdvisorShares Investments LLC | Increased | 252,909 | Aug 11, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 173,488 | Aug 13, 2026 |
| Shay Capital LLC | Increased | 155,822 | Aug 14, 2026 |
| ADVISORSHARES INVESTMENTS LLC | Increased | 155,367 | Apr 28, 2026 |
| SHAY CAPITAL LLC | Reduced | 151,010 | May 15, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | Increased | 142,228 | Aug 14, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | New Position | 142,183 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 98,516 | May 15, 2026 |
| Squadron Capital Management LLC | New Position | 76,728 | May 15, 2026 |
| CITADEL ADVISORS LLC | Increased | 72,559 | Sep 2, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 52,007 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 49,516 | Aug 12, 2026 |
| IKARIAN CAPITAL, LLC | Unchanged | 47,443 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jan 21, 2026